Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS’ EQUITY (Tables)

v3.26.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
SCHEDULE OF WARRANT ACTIVITY

Warrant activity for the nine months ended September 30, 2026 was as follows:

 

   

Number of

Warrants

   

Weighted Average

Exercise Price

 
             
Balance, December 31, 2025     3,882,755     $ 0.08  
Issued     —       —  
Expired or rescinded     (283 )     —  
Exercised     (157,662 )     0.08  
Balance, September 30, 2026     3,724,810     $ 0.08  
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per share of Class A common stock is as follows:

 

(in thousands, except share and per share data)   2026     2025     2026     2025  
    Three months ended
September 30,
    Nine months ended
September 30,
 
(in thousands, except share and per share data)   2026     2025     2026     2025  
Numerator:                                
Net income (loss)   $ 4,433     $ (8,933 )   $ (38,611 )   $ (16,015 )
Less: Net income (loss) attributable to non-controlling interests     —       —       149       —  
Net income (loss) attributable to Class A common stockholders   $ 4,433     $ (8,933 )   $ (38,760 )   $ (16,015 )
Denominator:                                
Weighted average shares of Class A common stock outstanding - basic     3,855,926       173,319       3,838,647       100,686  
Net income (loss) per share of Class A common stock - basic   $ 1.15     $ (51.54 )   $ (10.10 )   $ (159.06 )
Dilutive effect of warrants (treasury stock method)     557,939       —       —       —  
Weighted average shares of Class A common stock outstanding - diluted     4,413,865       173,319       3,838,647       100,686  
Net income (loss) per share of Class A common stock - diluted   $ 1.00     $ (51.54 )   $ (10.10 )   $ (159.06 )
SCHEDULE OF OUTSTANDING POTENTIALLY DILUTIVE SECURITIES

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net loss per share because their inclusion would be anti-dilutive (in common stock equivalent shares):

 

    2026     2025     2026     2025  
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
Stock options to purchase common stock     235,000       1       235,000       1  
Warrants to purchase common stock*     3,436       3,944       630,122       3,944  

 

  * Pre-funded warrants with nominal exercise prices are included in basic weighted-average shares and excluded from this table.